The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve

JACC Cardiovasc Interv. 2011 Oct;4(10):1093-5. doi: 10.1016/j.jcin.2011.08.007.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine / therapeutic use*
  • Adenosine A2 Receptor Antagonists*
  • Coronary Stenosis / diagnosis*
  • Coronary Vessels / pathology*
  • Female
  • Fractional Flow Reserve, Myocardial / drug effects*
  • Humans
  • Male
  • Purines*
  • Pyrazoles*
  • Vasodilator Agents / therapeutic use*

Substances

  • Adenosine A2 Receptor Antagonists
  • Purines
  • Pyrazoles
  • Vasodilator Agents
  • regadenoson
  • Adenosine